Clinicopathological discordance and survival outcomes in 154 breast cancer patients with pulmonary metastasis in a real-world setting
Ying Yan, Yifei Chen, Lijun Di, Xu Liang, Bin Shao, Hanfang Jiang, Guohong Song, Huiping Li · 2026
Read Clinicopathological discordance and survival outcomes in 154 breast cancer patients with pulmonary metastasis in a real-world setting by Ying Yan, Yifei Chen, Lijun Di, Xu Liang, Bin Shao, Hanfang Jiang, Guohong Song, Huiping Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13526734.txt.
Description
Ying Yan and colleagues analyze, in a 2026 real-world study, breast cancer that has spread to the lungs. They ask how often the metastasis changes hormone and growth receptor status compared with the original tumor. Such changes can redirect systemic therapy, and biopsies also separate true spread from a new primary lung cancer.
At Peking University Cancer Hospital between 2010 and 2024, 180 biopsied patients were identified from nearly three thousand with lung nodules. Of these, 154 proved to have breast cancer metastases while the rest had primary lung cancers. Among 128 patients with full receptor profiles, overall discordance was eighteen percent, highest for the progesterone receptor. Three-year survival differed sharply by metastatic subtype, exceeding ninety-four percent for hormone-positive groups but falling near sixty-five percent for triple-negative disease.
Catalog record
| CREATOR | Ying Yan, Yifei Chen, Lijun Di, Xu Liang, Bin Shao, Hanfang Jiang, Guohong Song, Huiping Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35641 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |